Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2006 | |
| Sales | 245,749 | 218,460 | 0 |
| Cost of Goods | 125,188 | 125,616 | N/A |
| Gross Profit | 120,561 | 92,844 | N/A |
| Operating Expenses | 172,817 | 125,508 | 0 |
| Operating Income | -52,068 | -32,049 | N/A |
| Interest Expense | 29,052 | 20,187 | 0 |
| Other Income | -4,522 | 169 | 0 |
| Pre-tax Income | -85,643 | -52,067 | 0 |
| Income Tax | -44,501 | -10,246 | N/A |
| Net Income Continuous | -41,142 | -41,821 | N/A |
| Net Income | $-41,142 | $-41,821 | $N/A |
| EPS Basic Total Ops | -0.96 | -41.81 | N/A |
| EPS Basic Continuous Ops | -0.96 | -41.82 | N/A |
| EPS Diluted Total Ops | -0.96 | -41.81 | N/A |
| EPS Diluted Continuous Ops | -0.96 | -41.82 | N/A |
| EBITDA(a) | $67,368 | $13,012 | $N/A |